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 ABSTRACT  
 
STUDY OBJECTIVE  To assess whether opportunistic and postal screening strategies for 
Chlamydia trachomatis can be compared with usual care in a randomised trial in general 
practice 
 
DESIGN:  Feasibility study for a randomised controlled trial. 
 
SETTING: Three West of Scotland general medical practices: one rural, one urban/deprived 
and one urban/affluent. 
 
PARTICIPANTS: 600 women aged 16-30 years, 200 from each of three participating 
practices selected at random from a sample of West of Scotland practices that had expressed 
interest in the study.  The women could opt out of the study.   Those who did not were 
randomly assigned to one of three groups: postal screening, opportunistic screening or usual 
care. 
 
MAIN RESULTS: 38% (85/221) of the approached practices expressed interest in the study.  
Data were collected successfully from the 3 participating practices, although intensive 
support was required.  There were considerable workload implications for staff, both in 
relation to implementing the screening strategies and managing the research process.   
 
124 of the 600 women opted out of the study.  During the four-month study period, 55% 
(81/146) of the control group attended their practice but none was offered screening.  59% 
(80/136) women in the opportunistic group attended their practice of whom 55% (44/80) 
were offered screening.  Of those, 64% (28/44) accepted, representing 21% of the 
opportunistic group.  48% (59/124) of the postal group returned samples.  
 
CONCLUSION:  A randomised controlled trial comparing postal and opportunistic 
screening for chlamydial infection in general practice is feasible, though resource intensive.  
There may be problems with generalising from screening trials in which patients may opt out 
from the offer of  screening. 
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 INTRODUCTION 
Approximately 3% of UK women aged between 18 and 24 years have undiagnosed genital 
Chlamydia trachomatis infection.[1]  The most serious sequelae of the infection are pelvic 
inflammatory disease, infertility and ectopic pregnancy.[2]  New sensitive urine tests can 
detect chlamydial DNA, making non-invasive screening and treatment of asymptomatic 
people feasible.[3] [4]  The costs of screening may be offset by the costs avoided of treating 
cases with long-term sequelae [5] [6] but this view has been challenged.[7] [8]  The true costs 
and benefits of screening can only be established in randomised controlled trials with long 
term follow up. 
 
If a national screening programme is to be introduced the best mechanism has to be 
established.[9]   Current UK guidelines recommend opportunistic screening of sexually active 
women aged less than 25 years and women between 25 and 30 years who have had new 
sexual partners in the previous year.[5] It has been proposed that opportunistic screening 
should be offered in general practice [5] [10] where reasonable population coverage has been 
obtained.[11]    An alternative, systematic screening strategy involves delivery of kits 
containing vaginal pipettes [12] or urine containers [13] to patients’ homes for return to the 
laboratory.  Regardless of method, doubts have been expressed about the knowledge base and 
attitudes of practice staff in relation to chlamydia screening.[14] [15]  Armstrong et al [15] 
reported that screening was commonly offered during attendance for cervical smears, but that 
this practice skewed offers of screening towards women over 20 years, a much lower risk 
population than teenagers.[1] 
 
There are no published trials comparing postal with opportunistic screening for genital 
chlamydial infection.  This feasibility study sought to establish the practical considerations 
for implementing a successful randomised controlled trial (RCT) of active screening 
strategies for genital chlamydial infection in general practice.  
 
METHODS 
 
THE PRACTICES  
We invited 221 West of Scotland general medical practices to participate.  Practices were 
given details of the work involved and of financial reimbursement (at hourly rates 
corresponding to normal salaries, with overtime paid at 50% above standard rates).  Using 
postcodes, practices agreeing to participate were stratified by location and deprivation into 
three types (rural, deprived urban and affluent urban). We classified deprivation categories 1 
and 2 as affluent and categories 6 and 7 as deprived.[16] [17]  One from each type was 
chosen at random to participate.  
 
In-practice training was organised for clinical and clerical staff.  A three-day course for 
practice nurses was provided by a sexual health advisor and three of the authors.  Course 
content included clinical features and management of chlamydia and other sexually 
transmitted infections; counselling; giving a positive result and partner notification.  
 
ETHICS AND DATA PROTECTION 
Three local research ethics committees (LRECs) granted ethics approval.  The first LREC we 
approached insisted that some form of consent from participants was required.  Women were 
sent an introductory letter describing the study and indicating that participation might involve 
receiving chlamydia test kits, questionnaires and data extraction from their records.  The 
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 option to opt out was offered at this stage. In two practices, women opting out were informed 
that information about postcode sector and year of birth would be collected.  In the third 
practice, the LREC required patients to have the choice of opting out without this information 
being used.  Patients who had not been sexually active were not asked to opt, but the 
introductory letter explained that chlamydial infection was sexually transmitted.  Women 
returning samples or questionnaires were asked to provide written consent. 
 
INTERVENTION PHASE (June-September 2002) 
Figure 1 summarises the study protocol.  Practice staff were given a procedure manual and 
continued support from the researcher by phone calls, emails and visits.  They were provided 
with templates for standard letters to be signed by the patient’s GP and sent to patients at 
different phases.   The mailing date was recorded on a slip attached to each pack and returned 
to the study office.  
 
FIGURE 1 ABOUT HERE 
 
Two hundred patients aged 16–30 years were selected from each practice list using the 
random sampling function in SPSS.  Women deemed unsuitable for the trial (eg those with 
terminal illness) were excluded by their GPs.  
 
One month after the initial mailing to patients, opt out slips were collated and the study list 
was amended and anonymised by practice staff.  The researcher used this anonymised list to 
allocate women randomly to one of three study groups: postal, opportunistic or control.  
 
Postal group: Women were sent pre-labelled test kits returnable to the laboratory in a reply-
paid, pre-addressed envelope; a chlamydia information leaflet and a consent form to be 
returned to the practice.  
Opportunistic group: Prior to the screening phase, casenotes of these women were flagged 
and identifier labels and a checklist for clinicians were placed inside the notes.  These women 
were to be offered screening when they attended the practice for any service during the four 
month study period.  Test kits were similar to those used for the postal group.  
Control group: Women in the control group were treated according to usual practice. 
 
On completion of the study period, practice nurses extracted data from medical records on all 
numbers and types of consultations in the study period and the preceding year, and on 
recorded consultations relating to sexual health during the whole period covered by their 
records.  
 
STAFF INTERVIEWS 
A sample of 13 staff (two GPs, one or two nurses and one or two administrative staff from 
each practice) was interviewed by one of the authors [MR] to obtain views on the workload 
associated with postal and opportunistic screening and on the benefits and obstacles 
associated with the screening and research processes.  The sampling strategy was designed to 
recruit staff who were directly involved in the rolling out of the research project, and this 
varied by practice.   Interviews were transcribed and analysed thematically, by coding 
responses into categories and themes, and looking for negative cases.  
 
STATISTICAL METHODS 
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 Data from practices and laboratories were recorded in Microsoft Access databases. 
Comparisons were made between practices and age groups (<20, 20-24 and > 25 years) using 
Fisher’s Exact Test in SPSS.  
 
Data from the opportunistic group were used to test whether women who visited their 
practice more often were more likely to be offered screening. Among attendees, the 
conditional probability of being offered screening and of accepting a test was estimated for 
the three age groups. 
 
Attendance data from all women over the year prior to screening were used to estimate the 
probabilities of attending the practice during a full year in each age group.  When combined 
with the conditional probabilities derived earlier, this permitted estimates of uptake rates in a 
study lasting for one year.  Similarly, given the rate of positive chlamydia results amongst 
those screened in the opportunistic group, the rate of positive results for the whole population 
if the screening programme were to run over a full year was estimated. 
 
RESULTS 
Of the 221 practices approached, 146 (66%) responded.  Of these, 62 (42%) responded 
positively, 23 (16%) expressed interest without commitment and 61 (42%) declined.  Data 
were collected successfully from the three participating practices.  
 
UPTAKE 
Figure 2 summarises participant numbers, study group allocation, screening uptake and 
questionnaire response rates. Opt-out rates did not vary significantly by practice or 
deprivation category.  Younger patients in the two practices with adequate data were 
somewhat more likely to opt out: 29/91 (32%) in the under-20 age group compared to 54/258 
(21%) among the over-20s (p=0.045). 
 
FIGURE 2 ABOUT HERE 
 
The study groups were well matched for age and deprivation category (Table 1). 
 
TABLE 1 ABOUT HERE 
 
There were no significant inter-practice differences in offers or uptake of postal or 
opportunistic screening.   
 
There was no significant attrition in offers of screening to the opportunistic group over the 
study period as measured by date of first attendance at the practice. We found no association 
between the number of visits to the practice and the probability of being offered a test.  Based 
on the consultation data for the previous year, we estimate that the overall uptake rate in the 
opportunistic group over one year would be approximately 30%. 
 
Most tests were offered by GPs (36 of 41 consultations where the clinician could be 
determined), mainly during consultations for non-gynaecological illnesses. One woman 
attended her GP requesting chlamydia screening. Three of the four offers by practice nurses 
occurred during consultations for cervical smears or contraception.  
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 Women between 20 and 24 years were least likely to attend their practice (19/45 Vs 61/91: 
p=0.024).  Among those who did attend, women under 20 years were most likely to be 
offered a test (15/18 Vs 29/61: p=0.0015).  In the interviews some GPs associated the 
condition with a younger age group and reported a tendency to target younger women 
routinely. 
 
In women under 20 years, uptake for opportunistic screening (9/15, 60%) was significantly 
higher than for postal screening (5/23, 22%) (p=0.036). The opportunistic screening 
acceptance rate was not significantly higher when considered as a proportion of those 
randomised to opportunistic screening (9/27, 33%) but, based on projections from 
consultation patterns in the preceding year, it would increase over a longer study period.  In 
women over 20 years who were offered a test the opportunistic uptake rate (19/29, 66%) was 
not significantly higher than in the postal group (54/101, 53%) (p=0.35).  The overall uptake 
rate was nevertheless significantly lower in the opportunistic group (28/136, 21%) compared 
to the postal group (59/124, 48%: p<0.0001) in this short study period.  
 
No woman in the control group was offered chlamydia testing during the screening phase. 
Comparisons of the control group with the other two intervention groups were therefore not 
performed. 
 
SAMPLE SIZE CALCULATION 
Sample size calculations for a definitive trial of opportunistic Vs postal screening (in terms of 
uptake and positivity rates) are presented in table 3. 
 
TABLE 3 ABOUT HERE 
 
ACCEPTABILITY:  
Questionnaires were sent to all 87 women who submitted specimens.  Responses are 
summarised in table 2.   
 
TABLE 2 ABOUT HERE 
 
Fourteen of the 25 respondents who were offered testing but did not submit samples (56%) 
either forgot about the request or lost the kit.  Only 2 respondents (8%) stated that they had 
not yet had sexual intercourse.  Fifteen (60%) considered the offer of testing appropriate, but 
seven (28%) considered it inappropriate.   56/59 (95%) respondents thought men should be 
offered screening.  
 
WOMEN WITH POSITIVE TEST RESULTS:  
All seven women who tested positive were requested to make an appointment to see the 
practice nurse.  Nevertheless, one woman in the rural practice attended her GP and one 
pregnant patient in the deprived practice sought treatment from her obstetrician. Three of the 
five women seen by practice nurses returned completed questionnaires. All three felt 
comfortable and reassured during the consultation and all had notified sexual partners. The 
practice nurses reported that they had found the training course informative and relevant to 
their practice. 
 
QUALITATIVE RESULTS FROM STAFF INTERVIEWS: 
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  The study was labour intensive and practice administrative staff reported problems with its 
management.  Staff worked additional hours to ensure distribution of study materials and 
collation of responses: “It’s finding the time to be able to devote someone or several people 
to do what is required… we had almost everybody in one Saturday so it was useful just to 
really to discuss the various aspects as well but to also just go through the list and update 
because it takes you far longer when you’re being interrupted” (administrator).  Difficulties 
were exacerbated during periods of short staffing.  
 
Some problems related to specific screening strategies.  For the postal group, test kits were 
bulky and staff had to deliver them to the local post office. This was especially problematic 
for the staff at the deprived practice, which had no local post office. There were anecdotal 
reports in this practice that test kits were tampered with and/or wrongly delivered: “They 
don’t always deliver (the mail), they don’t always deliver very quickly or in the case of some 
of the kits they just deliver them straight back to the practice without any attempt to deliver 
them to the patients… We do have a lot of mail that goes missing and that is something that is 
probably not going to change”(Administrator).  One GP expressed concern that postal 
screening could create difficulties within the homes of recipients. “The key concern was the 
mail shot going to someone, could be the daughter of strict parents or the wife of someone 
who is anxious about other relationships could cause a difficult situation for either of 
them”(GP). 
GPs also reported problems when offering opportunistic screening. These included 
difficulties in changing the focus of the consultation to chlamydia screening; feeling that it 
was inappropriate (especially if the consultation involved a mental health problem) and 
concerns about the time required to raise the issue of chlamydia: “As far as the clinical side I 
just find it a bit stressful –‘Oh there’s another opportunity gone’ and you know I’ve a busy 
surgery, and I’ve got to talk about this completely different subject and sometimes it may be 
relevant but more often than not its not been relevant……and the girl has not been that keen” 
(GP).   
 
The practice nurses were trained in management of confirmed chlamydial infection. They 
found the training had a broader value to them in their everyday practice and was beneficial. 
"It was very good, and the whole thing about contact tracing and giving people positive 
results and things like that, it made you think about it, it was very good...Information about 
when swabs should be at the lab in order to get good results, you know, things like that have 
impacted already on my practice" (practice nurse). 
 
 
5. DISCUSSION AND CONCLUSIONS 
 
Summary of main findings. 
This feasibility study established that opportunities exist in general practice to conduct 
clinical trials of differing approaches to screening.  Despite the high potential workload, 
almost two fifths of practices approached were interested in participation. Furthermore, the 
three participating practices showed a high level of commitment despite staffing shortages.  
Training sessions gave staff an understanding of the study but considerable support was 
required for the project to run smoothly.   
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 Uptake of screening was 48% of the target population with a postal approach and 21% over 
four months with an opportunistic approach (38% and 19% respectively if the number of 
women randomised is used as denominator). The apparent superiority of postal screening in 
this broad comparison may obscure the fact that younger women, who are at highest risk for 
chlamydial infection, may respond better to opportunistic screening.  In the interviews some 
GPs reported a tendency to target younger women in their routine practice, associating the 
condition with a younger age group.   This observation suggests that these GPs, unlike others 
[15] [18] had become aware of the population risk profile, possibly resulting from 
participation in the study. The practice nurses were enthusiastic about taking on 
responsibilities for sexual health work, but, compared to the GPs, they had far fewer 
consultations with younger women.  
 
Strengths and limitations of the study. 
The requirement to obtain consent prior to randomisation meant that participation was 
incomplete.  It is difficult to extrapolate findings from the research project to the clinical 
situation in which all eligible patients would be offered screening.   The three LRECs 
permitted us to use a design involving an initial pre-randomisation ‘opt out’ approach 
because randomisation to an offer of screening was considered a relatively benign 
intervention.  We were not able to establish what proportion of women who opted out did so 
because they had never been sexually active.  In a definitive study there could be a case for 
asking sexually inactive women not to opt out for this reason, but to return an empty sample 
container if offered a test.  This approach might nevertheless be considered by some as a 
form of indirect behavioural surveillance. 
 
The design involved individual rather than cluster randomisation.  This approach significantly 
increases statistical power, but it is more complicated for practices and runs the risk of 
introducing contamination of the study groups.  The finding that none of the women in the 
usual care group was offered screening suggests that contamination was probably not a major 
problem.  Nevertheless, awareness among clinicians and patients that they were participating 
in a trial may have artificially enhanced rates of offer and acceptance of screening.  
Alternatively, a universal, rather than experimental, opportunistic screening programme 
might be associated with a greater acceptability of testing and a higher proportion of women 
being offered screening as health professionals become more experienced.  The fact that none 
of the control group were tested might indicate a potential adverse effect of a screening 
programme: a belief among health care providers that screening of asymptomatic individuals 
is sufficient. 
 
Our study was based on women because opportunistic screening strategies have not been 
developed for the male population.  They generally have relatively mild clinical 
manifestations of chlamydia infection and are more likely than women to be infrequent 
attenders (31% of men and 15% of women aged 16-30 had not attended their GP in the last 
year – Scottish Household Survey 1999/2000: authors’ own analysis).  This is not an 
argument against screening men.  Successful screening programmes will depend in part on 
preventing re-infection by identifying and treating infected men, but it is likely that postal 
approaches will yield higher uptake rates among males [19]. 
 
Although questionnaire responses generally supported the offer of testing, the response rate 
among women who did not return samples was low.  Work in progress in Bristol and 
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 Birmingham will help to elucidate the attitudes of women declining tests (Rona Campbell, 
personal communication, July 2003). 
 
Comparison with existing literature 
The 48% uptake rate for postal tests obtained in our study is in keeping with data obtained in 
other European studies.[12] [13] [] [20]  The 83% uptake of postal screening among men and 
women aged 18-45 years in one practice[21] was achieved only after intensive follow-up of 
non-responders (John MacLeod, personal communication, April 2002).  
 
We estimate that 30% of those offered opportunistic screening would be tested over a one-
year period.  This figure lies below 49% screened in general practice in the Portsmouth study 
but is close to 24% screened in the Wirral [11] and 22% in one practice in Yorkshire.[22]   It 
is possible that the high level of population coverage in the Portsmouth study results partly 
from payments to practices for each test conducted. 
 
Although the numbers are small, the prevalence of chlamydial infection among those tested 
in the opportunistic group is higher than among the postal responders.  This is not surprising 
given that the clinicians appear to have targeted women at higher risk.  Our results parallel 
the higher prevalence levels obtained in the Portsmouth/Wirral opportunistic screening pilots 
compared with those in the Bristol/Birmingham postal studies. 
 
Implications for future research 
This was a very complex trial with a high level of involvement of practice staff in project 
management. In a larger trial, we recommend that identified practice staff members perform 
project work in protected (and reimbursed) time, rather than on an ad hoc basis.   Increasing 
the number of clinical contacts between young women and practice nurses may improve 
recruitment and workload management.  A cluster design, in which only one type of 
intervention would be offered by each practice, would simplify matters greatly and might 
give clearer results, but with loss of statistical power for a given sample size.   A typical intra-
cluster correlation coefficient of 0.1 for process variables in a trial of this type would inflate 
the necessary sample size approximately 21 times.[23] 
 
The impact of UK data protection and European human rights legislation on the design of this 
project was highly significant.  Research ethics committees in the UK may apply the 
legislative framework more vigorously than committees in other European nations.[24]  In 
our study, research staff were not able to examine any non-anonymised data without 
informed ‘opt-in’ consent, so a great deal of the project management work had to be 
conducted by practice staff.  The alternative, obtaining opt in consent to be offered screening, 
would reduce participation rates and greatly reduce the value of any future trial.   
 
Similar considerations now apply to all evaluations of population screening in primary care, 
with a serious risk that health service policy on screening will be based on inadequate 
evidence.  We believe that when new screening technologies are introduced, there is a strong 
case for the conduct of cluster randomised trials without individual patient consent to the 
offer of screening.[25] 
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What this paper adds: 
- A randomised controlled trial comparing postal and opportunistic screening for 
chlamydial infection in general practice is feasible, though resource intensive.   
- There may be problems with generalising from screening trials in which patients may opt 
out from the possibility of being offered screening. 
 
Policy Implications: 
- The evidence base for chlamydia screening is not robust.  Evaluation of screening 
strategies through randomised controlled trials is essential.  Trials of population screening 
are only meaningful if pre-randomisation opt-out rates are minimal.  Significant numbers 
of women opted out in our study, despite the use of ‘opt out’ (passive) consent. 
- Cluster randomised trials of screening may be more likely to succeed than trials with 
individual randomisation.  We consider random assignment to an offer of screening 
without consent and anonymised transmission of aggregate data from practices to 
researchers to be ethically sound. 
- Screening for genital Chlamydia trachomatis in primary care is feasible, but potentially 
resource-intensive.  If population-based screening were to be implemented, it is likely that 
optimal coverage would be achieved with a combination of postal and opportunistic 
screening. 
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 FIGURE 1.  
 
Patients randomised to 3 groups
Opt-outs 
3 practices,  
Random selection of 600 female patients 16-30 years
Explanatory letter with return envelope for opt-out 
Wait for 4 weeks for response 
 
Group 1: postal screening 
Letter of invitation, consent 
form, information leaflet, 
test kit with patient study 
number, date of birth. 
Invitation filed in GP notes, 
copy to study office.  
Group 2: Opportunistic 
screening 
Notes marked with sticker 
Opportunistically offered 
invitation letter, consent 
form, leaflet, test kit after 
discussion.  Swab if 
appropriate.  Study office 
notified if accepted or 
declined 
Return sample to lab 
Result letters to practices  and (via practice) to patients 
After 2weeks: 
Reminder to 
non-  
responders 
Sample not returned: 
acceptability 
questionnaire sent. 
after 1 month
Positive result: invitation to attend
At practice nurse consultation: 
Counselling, questionnaire re 
sexual activity discussed, 
contraception, pregnancy etc.  
Examination if required. 
Prescribed antibiotic. 
Advised re partner notification 
and contact slip offered.  Study 
office notified. 
Questionnaire 
given to 
decliners by 
clinician 
Negative result. 
Acceptability 
questionnaire sent 
along with result 
notification letter Seen by 
practice nurse: 
Questionnaire 
sent after 
4weeks 
Not yet seen by 
practice nurse: 
Reminder letter 
sent after 4weeks
Questionnaire 
reminder sent 
after 2weeks 
Questionnaire 
reminder sent 
after 2weeks 
End of study: peruse all GP notes for lab results, data on sexually transmitted infections, 
pregnancies, contraception etc in study period and preceding year 
Group 3: controls 
Routine screening 
practice 
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  Figure 2. 
 
 21 excluded by GP
455 randomised
105 opt outs 
Postal group 
124 
Opportunistic 
group 
136 
Control group 
146  
23 moved 
7 late opt-outs 
6 moved 
8 late opt-outs 
Visited practice 
80 
Returned sample 
59 (48% of those 
offered test*) 
Offered test 
44 
Returned sample 
28 (21% of those 
offered test**) 
Test positive 
3 (5%) 
Test positive 
4 (14%) 
Test negative 
56 
Returned 
questionnaire 
44 
Returned 
questionnaire
3 
Returned 
questionnaire
0 
Returned 
questionnaire 
12 
Returned sample
0 (0%) 
No sample 
65 
Returned Q 
23 
No sample 
16 
Returned Q 
2 
1 moved 
4 late opt-outs
Test negative 
24 
579 approached 
600 women identified
19 untraceable 
*38% of women randomised to postal group 
**19% of women randomised to opportunistic group 
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Table 1.  Baseline characteristics of  study groups. 
 
 
 Postal group Opportunistic group Control group 
N 124 146 136 
Age (mean + SD)  25.3 ± 4.6 24.5 ± 4.3 23.3 ± 4.0 
Deprivation category 1-2 
                                   3-5 
                                   6-7 
                                   Missing 
28 
47 
34 
15 
25 
58 
36 
17 
32 
48 
44 
22 
    
 PATIENT ACCEPTABILITY  
 
TABLE 2: QUESTIONNAIRE RETURNS AND PATIENT ACCEPTABILITY  
  P
o
s
t
a
l
 
O
p
p
o
r
t
u
n
i
s
t
i
c
 
 R
u
r
a
l
 
D
e
p
r
i
v
e
d
 
U
r
b
a
n
 
A
f
f
l
u
e
n
t
 
U
r
b
a
n
 
 <
2
0
 
y
e
a
r
s
 
2
0
-
2
4
 
y
e
a
r
s
 
2
5
+
 
y
e
a
r
s
 
 T
o
t
a
l
 
Questionnaires Returned N/Total 47/59 12/28     24/31 15/27 20/29 7/14 15/23 37/50 59/87
Questionnaires Returned (Negative Result) N/Total 44/56 11/24  22/29 13/24 20/27     
       
6/12 14/20 35/48 55/80
Questionnaires Returned (Positive Result) N/Total 3/3 1/4  2/2 2/3 0/2  1/2 1/3 2/2  4/7
Number (%) who thought approach was 
appropriate 
N 
% Respondents
43 
91% 
11 
92%  
23 
96% 
12 
80% 
19 
95%  
5 
71%
14 
93% 
35 
95%  
54 
92% 
Number (%) who thought information 
supplied was adequate 
N 
% Respondents
44 
94% 
11 
92%  
23 
96% 
13 
87% 
19 
95%  
6 
86%
15 
100%
34 
92%  
55 
92% 
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 TABLE 3.  SAMPLE SIZE CALCULATION 
Age 
16-19 
Age 
20-24 
Age 
25-30 
Sample size required to detect difference in: 
n per group 
Uptake rate at α=5% with 90% power, assuming true 
difference in uptake rate to be 50% of that observed in 
feasibility study  
1241 1024 145 
Positive test rate at α=5% with 90% power, assuming 
lower rate group to be 50% of higher rate group  736 708 2122 
 
 
 
 
 
COMPETING INTERESTS:  None 
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